Dr. Mark Leon Willenbring, MD

Dr. Willenbring practices at NYC Psychiatric Associates in San Diego, California.

Dr. Willenbring's NPI, 1003930124, was assigned on March 16, 2007. Dr. Willenbring graduated from University Of Minnesota Medical School in 1974. Dr. Willenbring's Minnesota license number on file is 22040.

Dr. Willenbring's primary practice is NYC Psychiatric Associates, at 6755 Mira Mesa Blvd, San Diego, CA 92121 in San Diego County. The practice phone is (917) 391-0076.

Dr. Willenbring's primary practice is NYC Psychiatric Associates in San Diego, California. The medical group on file is NYC Psychiatric Associates. Dmand AI also links Dr. Willenbring to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Willenbring practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Willenbring's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Willenbring is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Willenbring's licenses on file in 15 states: Minnesota, South Dakota, Colorado, West Virginia, Arkansas, Georgia, Hawaii, Illinois, Oklahoma, Rhode Island, Arizona, California, Florida, Indiana and Massachusetts.

CMS data shows 41 Medicare services from Dr. Willenbring across 1 procedure code in 2016, all of them office visits. Medicare paid $2,999 for them. Every service was in an office.

Across all payers, Dmand AI patient panel data puts Dr. Willenbring's median patient age at 33, with 51% women.

In 2024, Dr. Willenbring wrote 75 Medicare Part D claims. 96% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $381 in total drug cost. In 2021, CMS named 173 claims across 9 drugs.

Dmand AI links 68 papers to Dr. Willenbring, published from 2006 to 2013. 2006 was the busiest year, with 2. The most frequent topics are Alcoholism, Substance-Related Disorders and Minnesota. Dr. Willenbring has published most often in Alcohol Clin Exp Res. Dr. Willenbring's most frequent co-authors are Steven S. Fu, MD, Libin Ho, MD, PhD and Bankole A. Johnson, MD.

CMS Open Payments shows 3 general payments to Dr. Willenbring from 2 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Shire North American Group Inc paid the most, $26.

Dmand AI lists 17 awards for Dr. Willenbring, most recently CMS Stage 1 EHR in 2011.

Dr. Willenbring graduated from University Of Minnesota Medical School in 1974. Dr. Willenbring is a member of American Academy of Addiction Psychiatry, APA and ASAM.

Dr. Willenbring is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.